About Sonexa Therapeutics

Sonexa Therapeutics, Inc., a pharmaceutical company, engages in the development of therapeutics drugs for the treatment of Alzheimer's disease and related disorders. It develops ST101, a small and orally active molecule compound that penetrates the blood-brain-barrier. The company was incorporated in 2007 and is based in San Diego, California.

Top 100 in Health Care
Top 100 in Pharmaceutical
Top 100 in Therapeutics
Top 100 in Biotechnology
Company Highlights
Year Founded

2007

icon-altEmployees

1

Location (HQ)

USA

Since Last Funding

12 years 1 month

icon-altTotal Investment Amt

$41M

icon-altYoY Headcount Growth

1000%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology

Biotechnology Research

Pharmaceutical

Therapeutics